Aclaris: 2Q Earnings Snapshot
Aug. 03, 2018
WAYNE, Pa. (AP) _ Aclaris Therapeutics Inc. (ACRS) on Friday reported a loss of $31.2 million in its second quarter.
The Wayne, Pennsylvania-based company said it had a loss of $1.01 per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.
The specialty pharmaceutical company posted revenue of $3.7 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $2.8 million.
Aclaris shares have declined 27 percent since the beginning of the year. The stock has declined 35 percent in the last 12 months.